查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
全球蝦病診斷市場 - 全球產業分析、規模、份額、成長、趨勢、預測 (2031) - 按產品、按技術、按等級、按應用、按最終用戶、按地區
市場調查報告書
商品編碼
1394147

全球蝦病診斷市場 - 全球產業分析、規模、份額、成長、趨勢、預測 (2031) - 按產品、按技術、按等級、按應用、按最終用戶、按地區

Shrimp Disease Diagnostics Market - Global Industry Analysis, Size, Share, Growth, Trends, & Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America & Middle East & Africa)
出版日期: | 出版商: Fairfield Market Research | 英文 215 Pages | 商品交期: 2-5個工作天內

價格
簡介目錄

預計2024年全球蝦病診斷市場收入將達到約4.84億美元，到2031年底將達到約8億美元，增長顯著。馬蘇。 在全球對蝦需求迅速增長的推動下，這個蓬勃發展的行業是動物診斷行業的關鍵組成部分。

蝦是世界各地海鮮消費的主食，對蝦子的需求不斷增加，是蝦病診斷市場擴大的驅動因素。 蝦養殖對人類食物和營養供應至關重要，而這種需求是由海蝦和淡水蝦生產所驅動的。 蝦子病診斷在維持蝦類健康、防止傳染病傳播和保護蝦類養殖的可持續性方面發揮著至關重要的作用。

早期檢測對於白斑症候群 (WSS) 等威脅尤其重要，目前對此的治療方法有限。 PCR 和 DNA 雜交等先進診斷工具有助於增強生物安全並促進對蝦養殖的最佳管理實踐。

儘管蝦病診斷市場的成長軌跡充滿希望，但仍面臨一些挑戰。 實驗室中的密集疾病檢測成本高、耗時，並且需要專門的設施和熟練的人員。 一些地區的蝦病診斷監管框架仍然不發達，這可能會阻礙市場成長。

此外，在亞洲等發展中國家，需要加強檢疫、監測和疾病識別能力，這對於降低與活體動物進口相關的疾病傳播風險至關重要。 一些地區已經制定了管理法規來保護國內甲殼類動物種群並確保可持續的做法。

本報告研究了全球身分和存取管理市場，提供了市場概述、按組件、部署、解決方案、行業、區域劃分的趨勢以及市場參與者之間的競爭趨勢。

目錄

第 1 章執行摘要

第二章市場概述

  • 市場定義與細分
  • 市場動態
  • 價值鏈分析
  • 波特五力分析
  • 新冠肺炎 (COVID-19) 影響分析
  • 烏克蘭和俄羅斯之間衝突的影響
  • 經濟概況
  • 杵分析

第三章2018-2031年全球蝦子病診斷市場前景

  • 2018-2031 年全球蝦子病診斷市場前景（以試劑、金額劃分）
  • 2018-2031 年全球蝦子病診斷市場前景（按疾病、價值劃分）
  • 2018-2031 年全球蝦子病診斷市場前景（按最終用戶劃分）、價值
  • 2018-2031 年全球蝦子病診斷市場前景（按地區、價值劃分）

第 4 章北美蝦病診斷市場前景，2018-2031

第 5 章歐洲蝦病診斷市場前景，2018-2031

第 6 章亞太地區蝦病診斷市場展望，2018-2031 年

第 7 章拉丁美洲蝦病診斷市場展望，2018-2031

第 8 章中東與非洲蝦病診斷市場前景，2018-2031

第九章競爭態勢

  • 疾病與試劑的熱圖
  • 2023 年公司市佔率分析
  • 競爭力儀表板
  • 公司簡介
    • HiMedia Laboratories
    • Speedy Assay Sdn Bhd
    • REAGEN LLC
    • FUJIKURA KASEI CO., LTD.
    • GeneReach Biotechnology Corp.
    • Thermo Fisher Scientific
    • Lab - Ind Resource Sdn Bhd.
    • SUREBIO
    • Auro Biotechnologies Pvt. Ltd.

第 10 章附錄

簡介目錄

The global Shrimp Disease Diagnostics Market is poised for remarkable growth, with revenues reaching approximately US$ 484.0 Million in 2024 and a projected valuation of about US$ 800.0 Million by the end of 2031, according to recent report by Fairfield Market Research. This thriving sector is a vital component of the animal diagnostics industry, propelled by the surging global demand for shrimp.

Biosecurity for Healthy Shrimps and Disease Prevention

The escalating demand for shrimp, a staple in global seafood consumption, has been a driving force behind the expansion of the shrimp disease diagnostics market. Shrimp aquaculture is crucial for human food and nutrition supply, and this demand is driven by both marine and freshwater shrimp production. Shrimp disease diagnostics play a pivotal role in maintaining the health of shrimp populations, preventing the spread of infectious diseases, and safeguarding the sustainability of shrimp farming.

In particular, the market has witnessed an increased focus on early disease detection, especially for threats like White Spot Syndrome (WSS), where therapeutic options are currently limited. Advanced diagnostic tools, such as PCR and DNA hybridization, have been instrumental in enhancing biosecurity and promoting best management practices in shrimp farming.

Challenges and Opportunities

Despite its promising growth trajectory, the shrimp disease diagnostics market faces several challenges. The centralized nature of disease detection in laboratories can be costly and time-consuming, demanding specialized facilities and skilled personnel. Regulatory frameworks for shrimp disease diagnostics are still evolving in some regions, potentially impeding market growth.

In addition, the need for enhanced capacity in developing nations, such as those in Asia, to carry out quarantine, surveillance, and disease identification is critical to mitigate disease transmission risks associated with live animal importation. Some regions have already implemented management regulations to protect domestic crustacean populations and ensure sustainable practices.

Country-wise Insights

United States: The U.S. market is set to expand the global market due to its access to advanced molecular diagnostic tools. Factors such as a higher prevalence of infections, rising healthcare expenditure, efficient healthcare infrastructures, and skilled laboratory technicians are contributing to market growth. Collaborations within the aquaculture industry are furthering the focus on health management and disease prevention.

China: As the world's largest consumer of seafood, China is a dominant player in shrimp farming and disease diagnostics. Government regulations ensure seafood safety and quality, prompting an increased demand for disease diagnostics to comply with these standards. Innovations like real-time PCR and ELISA assays have enhanced diagnosis accuracy and speed, further driving adoption.

Germany: Germany's significant seafood market and rising shrimp demand have led to a greater need for effective disease diagnostics. The presence of key market players in the shrimp disease diagnostics market has increased product availability and competition. The incidence of shrimp diseases in the region, including WSSV, YHV, and TSV, has also surged.

Competitive Landscape

Key players in the shrimp disease diagnostics market are actively collaborating with ISO-accredited government laboratories and universities to develop and commercialize innovative diagnostic products. These collaborations aim to leverage advanced technologies for manufacturing genetic diagnostics tools.

Notable companies in the market include:

  • HiMedia Laboratories
  • Speedy Assay Sdn Bhd
  • REAGEN LLC
  • FUJIKURA KASEI CO., LTD.
  • GeneReach Biotechnology Corp.
  • Thermo Fisher Scientific
  • Lab - Ind Resource Sdn Bhd.
  • SUREBIO
  • Auro Biotechnologies Pvt. Ltd.

Key Segments Covered in Shrimp disease diagnostics Industry Research

Reagent:

  • Rapid Testing Kits
  • Assay Based Kits

Disease:

  • WSSV (White Spot Syndrome Virus)
  • TSV (Taura Syndrome Virus)
  • YHV/GAV (Yellow Head/Gill Associated Virus)
  • IHHNV (Infectious Hypodermal and Hematopoietic Virus)
  • HPV (Hepatopancreatic Parvovirus)
  • MBV (Monodon Baculovirus)
  • IMNV (Infectious Myonecrosis Virus)
  • NHP-B (Necrotising Hepatopancreatitis Bacteria)
  • MoV (Mourilyan Virus)
  • Early Mortality Syndrome (EMS)

End User:

  • Fisheries
  • Aquaculture Laboratories
  • Marine Laboratories
  • Education and Research Institutes
  • Others

Region:

  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • Middle East and Africa (MEA)

Table of Contents

1. Executive Summary

  • 1.1. Global Shrimp Disease Diagnostics Market Snapshot
  • 1.2. Future Projections
  • 1.3. Key Market Trends
  • 1.4. Regional Snapshot, by Value, 2023
  • 1.5. Analyst Recommendations

2. Market Overview

  • 2.1. Market Definitions and Segmentations
  • 2.2. Market Dynamics
    • 2.2.1. Drivers
    • 2.2.2. Restraints
    • 2.2.3. Market Opportunities
  • 2.3. Value Chain Analysis
  • 2.4. Porter's Five Forces Analysis
  • 2.5. COVID-19 Impact Analysis
    • 2.5.1. Supply
    • 2.5.2. Demand
  • 2.6. Impact of Ukraine-Russia Conflict
  • 2.7. Economic Overview
    • 2.7.1. World Economic Projections
  • 2.8. PESTLE Analysis

3. Global Shrimp Disease Diagnostics Market Outlook, 2018 - 2031

  • 3.1. Global Shrimp Disease Diagnostics Market Outlook, by Reagent, Value (US$ Bn), 2018 - 2031
    • 3.1.1. Key Highlights
      • 3.1.1.1. Rapid Testing Kits
      • 3.1.1.2. Assay Based Kits
  • 3.2. Global Shrimp Disease Diagnostics Market Outlook, by Disease, Value (US$ Bn), 2018 - 2031
    • 3.2.1. Key Highlights
      • 3.2.1.1. WSSV (White Spot Syndrome Virus)
      • 3.2.1.2. TSV (Taura Syndrome Virus)
      • 3.2.1.3. YHV/GAV (Yellow Head/Gill Associated Virus)
      • 3.2.1.4. IHHNV (Infectious Hypodermal and Hematopoietic Virus)
      • 3.2.1.5. HPV (Hepatopancreatic Parvovirus)
      • 3.2.1.6. MBV (Monodon Baculovirus)
      • 3.2.1.7. IMNV (Infectious Myonecrosis Virus)
      • 3.2.1.8. NHP-B (Necrotising Hepatopancreatitis Bacteria)
      • 3.2.1.9. MoV (Mourilyan Virus)
      • 3.2.1.10. Early Mortality Syndrome (EMS)
  • 3.3. Global Shrimp Disease Diagnostics Market Outlook, by End User, Value (US$ Bn), 2018 - 2031
    • 3.3.1. Key Highlights
      • 3.3.1.1. Fisheries
      • 3.3.1.2. Aquaculture Laboratories
      • 3.3.1.3. Marine Laboratories
      • 3.3.1.4. Education and Research Institutes
      • 3.3.1.5. Others
  • 3.4. Global Shrimp Disease Diagnostics Market Outlook, by Region, Value (US$ Bn), 2018 - 2031
    • 3.4.1. Key Highlights
      • 3.4.1.1. North America
      • 3.4.1.2. Europe
      • 3.4.1.3. Asia Pacific
      • 3.4.1.4. Latin America
      • 3.4.1.5. Middle East & Africa

4. North America Shrimp Disease Diagnostics Market Outlook, 2018 - 2031

  • 4.1. North America Shrimp Disease Diagnostics Market Outlook, by Reagent, Value (US$ Bn), 2018 - 2031
    • 4.1.1. Key Highlights
      • 4.1.1.1. Rapid Testing Kits
      • 4.1.1.2. Assay Based Kits
  • 4.2. North America Shrimp Disease Diagnostics Market Outlook, by Disease, Value (US$ Bn), 2018 - 2031
    • 4.2.1. Key Highlights
      • 4.2.1.1. WSSV (White Spot Syndrome Virus)
      • 4.2.1.2. TSV (Taura Syndrome Virus)
      • 4.2.1.3. YHV/GAV (Yellow Head/Gill Associated Virus)
      • 4.2.1.4. IHHNV (Infectious Hypodermal and Hematopoietic Virus)
      • 4.2.1.5. HPV (Hepatopancreatic Parvovirus)
      • 4.2.1.6. MBV (Monodon Baculovirus)
      • 4.2.1.7. IMNV (Infectious Myonecrosis Virus)
      • 4.2.1.8. NHP-B (Necrotising Hepatopancreatitis Bacteria)
      • 4.2.1.9. MoV (Mourilyan Virus)
      • 4.2.1.10. Early Mortality Syndrome (EMS)
  • 4.3. North America Shrimp Disease Diagnostics Market Outlook, by End User, Value (US$ Bn), 2018 - 2031
    • 4.3.1. Key Highlights
      • 4.3.1.1. Fisheries
      • 4.3.1.2. Aquaculture Laboratories
      • 4.3.1.3. Marine Laboratories
      • 4.3.1.4. Education and Research Institutes
      • 4.3.1.5. Others
  • 4.4. North America Shrimp Disease Diagnostics Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
    • 4.4.1. Key Highlights
      • 4.4.1.1. U.S. Shrimp Disease Diagnostics Market by Reagent, Value (US$ Bn), 2018 - 2031
      • 4.4.1.2. U.S. Shrimp Disease Diagnostics Market by Disease, Value (US$ Bn), 2018 - 2031
      • 4.4.1.3. U.S. Shrimp Disease Diagnostics Market by End User, Value (US$ Bn), 2018 - 2031
      • 4.4.1.4. Canada Shrimp Disease Diagnostics Market by Reagent, Value (US$ Bn), 2018 - 2031
      • 4.4.1.5. Canada Shrimp Disease Diagnostics Market by Disease, Value (US$ Bn), 2018 - 2031
      • 4.4.1.6. Canada Shrimp Disease Diagnostics Market by End User, Value (US$ Bn), 2018 - 2031
    • 4.4.2. BPS Analysis/Market Attractiveness Analysis

5. Europe Shrimp Disease Diagnostics Market Outlook, 2018 - 2031

  • 5.1. Europe Shrimp Disease Diagnostics Market Outlook, by Reagent, Value (US$ Bn), 2018 - 2031
    • 5.1.1. Key Highlights
      • 5.1.1.1. Rapid Testing Kits
      • 5.1.1.2. Assay Based Kits
  • 5.2. Europe Shrimp Disease Diagnostics Market Outlook, by Disease, Value (US$ Bn), 2018 - 2031
    • 5.2.1. Key Highlights
      • 5.2.1.1. WSSV (White Spot Syndrome Virus)
      • 5.2.1.2. TSV (Taura Syndrome Virus)
      • 5.2.1.3. YHV/GAV (Yellow Head/Gill Associated Virus)
      • 5.2.1.4. IHHNV (Infectious Hypodermal and Hematopoietic Virus)
      • 5.2.1.5. HPV (Hepatopancreatic Parvovirus)
      • 5.2.1.6. MBV (Monodon Baculovirus)
      • 5.2.1.7. IMNV (Infectious Myonecrosis Virus)
      • 5.2.1.8. NHP-B (Necrotising Hepatopancreatitis Bacteria)
      • 5.2.1.9. MoV (Mourilyan Virus)
      • 5.2.1.10. Early Mortality Syndrome (EMS)
  • 5.3. Europe Shrimp Disease Diagnostics Market Outlook, by End User, Value (US$ Bn), 2018 - 2031
    • 5.3.1. Key Highlights
      • 5.3.1.1. Fisheries
      • 5.3.1.2. Aquaculture Laboratories
      • 5.3.1.3. Marine Laboratories
      • 5.3.1.4. Education and Research Institutes
      • 5.3.1.5. Others
  • 5.4. Europe Shrimp Disease Diagnostics Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
    • 5.4.1. Key Highlights
      • 5.4.1.1. Germany Shrimp Disease Diagnostics Market by Reagent, Value (US$ Bn), 2018 - 2031
      • 5.4.1.2. Germany Shrimp Disease Diagnostics Market by Disease, Value (US$ Bn), 2018 - 2031
      • 5.4.1.3. Germany Shrimp Disease Diagnostics Market by End User, Value (US$ Bn), 2018 - 2031
      • 5.4.1.4. U.K. Shrimp Disease Diagnostics Market by Reagent, Value (US$ Bn), 2018 - 2031
      • 5.4.1.5. U.K. Shrimp Disease Diagnostics Market by Disease, Value (US$ Bn), 2018 - 2031
      • 5.4.1.6. U.K. Shrimp Disease Diagnostics Market by End User, Value (US$ Bn), 2018 - 2031
      • 5.4.1.7. France Shrimp Disease Diagnostics Market by Reagent, Value (US$ Bn), 2018 - 2031
      • 5.4.1.8. France Shrimp Disease Diagnostics Market by Disease, Value (US$ Bn), 2018 - 2031
      • 5.4.1.9. France Shrimp Disease Diagnostics Market by End User, Value (US$ Bn), 2018 - 2031
      • 5.4.1.10. Italy Shrimp Disease Diagnostics Market by Reagent, Value (US$ Bn), 2018 - 2031
      • 5.4.1.11. Italy Shrimp Disease Diagnostics Market by Disease, Value (US$ Bn), 2018 - 2031
      • 5.4.1.12. Italy Shrimp Disease Diagnostics Market by End User, Value (US$ Bn), 2018 - 2031
      • 5.4.1.13. Turkey Shrimp Disease Diagnostics Market by Reagent, Value (US$ Bn), 2018 - 2031
      • 5.4.1.14. Turkey Shrimp Disease Diagnostics Market by Disease, Value (US$ Bn), 2018 - 2031
      • 5.4.1.15. Turkey Shrimp Disease Diagnostics Market by End User, Value (US$ Bn), 2018 - 2031
      • 5.4.1.16. Russia Shrimp Disease Diagnostics Market by Reagent, Value (US$ Bn), 2018 - 2031
      • 5.4.1.17. Russia Shrimp Disease Diagnostics Market by Disease, Value (US$ Bn), 2018 - 2031
      • 5.4.1.18. Russia Shrimp Disease Diagnostics Market by End User, Value (US$ Bn), 2018 - 2031
      • 5.4.1.19. Rest of Europe Shrimp Disease Diagnostics Market by Reagent, Value (US$ Bn), 2018 - 2031
      • 5.4.1.20. Rest of Europe Shrimp Disease Diagnostics Market by Disease, Value (US$ Bn), 2018 - 2031
      • 5.4.1.21. Rest of Europe Shrimp Disease Diagnostics Market by End User, Value (US$ Bn), 2018 - 2031
    • 5.4.2. BPS Analysis/Market Attractiveness Analysis

6. Asia Pacific Shrimp Disease Diagnostics Market Outlook, 2018 - 2031

  • 6.1. Asia Pacific Shrimp Disease Diagnostics Market Outlook, by Reagent, Value (US$ Bn), 2018 - 2031
    • 6.1.1. Key Highlights
      • 6.1.1.1. Rapid Testing Kits
      • 6.1.1.2. Assay Based Kits
  • 6.2. Asia Pacific Shrimp Disease Diagnostics Market Outlook, by Disease, Value (US$ Bn), 2018 - 2031
    • 6.2.1. Key Highlights
      • 6.2.1.1. WSSV (White Spot Syndrome Virus)
      • 6.2.1.2. TSV (Taura Syndrome Virus)
      • 6.2.1.3. YHV/GAV (Yellow Head/Gill Associated Virus)
      • 6.2.1.4. IHHNV (Infectious Hypodermal and Hematopoietic Virus)
      • 6.2.1.5. HPV (Hepatopancreatic Parvovirus)
      • 6.2.1.6. MBV (Monodon Baculovirus)
      • 6.2.1.7. IMNV (Infectious Myonecrosis Virus)
      • 6.2.1.8. NHP-B (Necrotising Hepatopancreatitis Bacteria)
      • 6.2.1.9. MoV (Mourilyan Virus)
      • 6.2.1.10. Early Mortality Syndrome (EMS)
  • 6.3. Asia Pacific Shrimp Disease Diagnostics Market Outlook, by End User, Value (US$ Bn), 2018 - 2031
    • 6.3.1. Key Highlights
      • 6.3.1.1. Fisheries
      • 6.3.1.2. Aquaculture Laboratories
      • 6.3.1.3. Marine Laboratories
      • 6.3.1.4. Education and Research Institutes
      • 6.3.1.5. Others
  • 6.4. Asia Pacific Shrimp Disease Diagnostics Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
    • 6.4.1. Key Highlights
      • 6.4.1.1. China Shrimp Disease Diagnostics Market by Reagent, Value (US$ Bn), 2018 - 2031
      • 6.4.1.2. China Shrimp Disease Diagnostics Market by Disease, Value (US$ Bn), 2018 - 2031
      • 6.4.1.3. China Shrimp Disease Diagnostics Market by End User, Value (US$ Bn), 2018 - 2031
      • 6.4.1.4. Japan Shrimp Disease Diagnostics Market by Reagent, Value (US$ Bn), 2018 - 2031
      • 6.4.1.5. Japan Shrimp Disease Diagnostics Market by Disease, Value (US$ Bn), 2018 - 2031
      • 6.4.1.6. Japan Shrimp Disease Diagnostics Market by End User, Value (US$ Bn), 2018 - 2031
      • 6.4.1.7. South Korea Shrimp Disease Diagnostics Market by Reagent, Value (US$ Bn), 2018 - 2031
      • 6.4.1.8. South Korea Shrimp Disease Diagnostics Market by Disease, Value (US$ Bn), 2018 - 2031
      • 6.4.1.9. South Korea Shrimp Disease Diagnostics Market by End User, Value (US$ Bn), 2018 - 2031
      • 6.4.1.10. India Shrimp Disease Diagnostics Market by Reagent, Value (US$ Bn), 2018 - 2031
      • 6.4.1.11. India Shrimp Disease Diagnostics Market by Disease, Value (US$ Bn), 2018 - 2031
      • 6.4.1.12. India Shrimp Disease Diagnostics Market by End User, Value (US$ Bn), 2018 - 2031
      • 6.4.1.13. Southeast Asia Shrimp Disease Diagnostics Market by Reagent, Value (US$ Bn), 2018 - 2031
      • 6.4.1.14. Southeast Asia Shrimp Disease Diagnostics Market by Disease, Value (US$ Bn), 2018 - 2031
      • 6.4.1.15. Southeast Asia Shrimp Disease Diagnostics Market by End User, Value (US$ Bn), 2018 - 2031
      • 6.4.1.16. Rest of Asia Pacific Shrimp Disease Diagnostics Market by Reagent, Value (US$ Bn), 2018 - 2031
      • 6.4.1.17. Rest of Asia Pacific Shrimp Disease Diagnostics Market by Disease, Value (US$ Bn), 2018 - 2031
      • 6.4.1.18. Rest of Asia Pacific Shrimp Disease Diagnostics Market by End User, Value (US$ Bn), 2018 - 2031
    • 6.4.2. BPS Analysis/Market Attractiveness Analysis

7. Latin America Shrimp Disease Diagnostics Market Outlook, 2018 - 2031

  • 7.1. Latin America Shrimp Disease Diagnostics Market Outlook, by Reagent, Value (US$ Bn), 2018 - 2031
    • 7.1.1. Key Highlights
      • 7.1.1.1. Rapid Testing Kits
      • 7.1.1.2. Assay Based Kits
  • 7.2. Latin America Shrimp Disease Diagnostics Market Outlook, by Disease, Value (US$ Bn), 2018 - 2031
      • 7.2.1.1. WSSV (White Spot Syndrome Virus)
      • 7.2.1.2. TSV (Taura Syndrome Virus)
      • 7.2.1.3. YHV/GAV (Yellow Head/Gill Associated Virus)
      • 7.2.1.4. IHHNV (Infectious Hypodermal and Hematopoietic Virus)
      • 7.2.1.5. HPV (Hepatopancreatic Parvovirus)
      • 7.2.1.6. MBV (Monodon Baculovirus)
      • 7.2.1.7. IMNV (Infectious Myonecrosis Virus)
      • 7.2.1.8. NHP-B (Necrotising Hepatopancreatitis Bacteria)
      • 7.2.1.9. MoV (Mourilyan Virus)
      • 7.2.1.10. Early Mortality Syndrome (EMS)
  • 7.3. Latin America Shrimp Disease Diagnostics Market Outlook, by End User, Value (US$ Bn), 2018 - 2031
    • 7.3.1. Key Highlights
      • 7.3.1.1. Fisheries
      • 7.3.1.2. Aquaculture Laboratories
      • 7.3.1.3. Marine Laboratories
      • 7.3.1.4. Education and Research Institutes
      • 7.3.1.5. Others
  • 7.4. Latin America Shrimp Disease Diagnostics Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
    • 7.4.1. Key Highlights
      • 7.4.1.1. Brazil Shrimp Disease Diagnostics Market by Reagent, Value (US$ Bn), 2018 - 2031
      • 7.4.1.2. Brazil Shrimp Disease Diagnostics Market by Disease, Value (US$ Bn), 2018 - 2031
      • 7.4.1.3. Brazil Shrimp Disease Diagnostics Market by End User, Value (US$ Bn), 2018 - 2031
      • 7.4.1.4. Mexico Shrimp Disease Diagnostics Market by Reagent, Value (US$ Bn), 2018 - 2031
      • 7.4.1.5. Mexico Shrimp Disease Diagnostics Market by Disease, Value (US$ Bn), 2018 - 2031
      • 7.4.1.6. Mexico Shrimp Disease Diagnostics Market by End User, Value (US$ Bn), 2018 - 2031
      • 7.4.1.7. Argentina Shrimp Disease Diagnostics Market by Reagent, Value (US$ Bn), 2018 - 2031
      • 7.4.1.8. Argentina Shrimp Disease Diagnostics Market by Disease, Value (US$ Bn), 2018 - 2031
      • 7.4.1.9. Argentina Shrimp Disease Diagnostics Market by End User, Value (US$ Bn), 2018 - 2031
      • 7.4.1.10. Rest of Latin America Shrimp Disease Diagnostics Market by Reagent, Value (US$ Bn), 2018 - 2031
      • 7.4.1.11. Rest of Latin America Shrimp Disease Diagnostics Market by Disease, Value (US$ Bn), 2018 - 2031
      • 7.4.1.12. Rest of Latin America Shrimp Disease Diagnostics Market by End User, Value (US$ Bn), 2018 - 2031
    • 7.4.2. BPS Analysis/Market Attractiveness Analysis

8. Middle East & Africa Shrimp Disease Diagnostics Market Outlook, 2018 - 2031

  • 8.1. Middle East & Africa Shrimp Disease Diagnostics Market Outlook, by Reagent, Value (US$ Bn), 2018 - 2031
    • 8.1.1. Key Highlights
      • 8.1.1.1. Rapid Testing Kits
      • 8.1.1.2. Assay Based Kits
  • 8.2. Middle East & Africa Shrimp Disease Diagnostics Market Outlook, by Disease, Value (US$ Bn), 2018 - 2031
    • 8.2.1. Key Highlights
      • 8.2.1.1. WSSV (White Spot Syndrome Virus)
      • 8.2.1.2. TSV (Taura Syndrome Virus)
      • 8.2.1.3. YHV/GAV (Yellow Head/Gill Associated Virus)
      • 8.2.1.4. IHHNV (Infectious Hypodermal and Hematopoietic Virus)
      • 8.2.1.5. HPV (Hepatopancreatic Parvovirus)
      • 8.2.1.6. MBV (Monodon Baculovirus)
      • 8.2.1.7. IMNV (Infectious Myonecrosis Virus)
      • 8.2.1.8. NHP-B (Necrotising Hepatopancreatitis Bacteria)
      • 8.2.1.9. MoV (Mourilyan Virus)
      • 8.2.1.10. Early Mortality Syndrome (EMS)
  • 8.3. Middle East & Africa Shrimp Disease Diagnostics Market Outlook, by End User, Value (US$ Bn), 2018 - 2031
    • 8.3.1. Key Highlights
      • 8.3.1.1. Fisheries
      • 8.3.1.2. Aquaculture Laboratories
      • 8.3.1.3. Marine Laboratories
      • 8.3.1.4. Education and Research Institutes
      • 8.3.1.5. Others
  • 8.4. Middle East & Africa Shrimp Disease Diagnostics Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
    • 8.4.1. Key Highlights
      • 8.4.1.1. GCC Shrimp Disease Diagnostics Market by Reagent, Value (US$ Bn), 2018 - 2031
      • 8.4.1.2. GCC Shrimp Disease Diagnostics Market by Disease, Value (US$ Bn), 2018 - 2031
      • 8.4.1.3. GCC Shrimp Disease Diagnostics Market by End User, Value (US$ Bn), 2018 - 2031
      • 8.4.1.4. South Africa Shrimp Disease Diagnostics Market by Reagent, Value (US$ Bn), 2018 - 2031
      • 8.4.1.5. South Africa Shrimp Disease Diagnostics Market by Disease, Value (US$ Bn), 2018 - 2031
      • 8.4.1.6. South Africa Shrimp Disease Diagnostics Market by End User, Value (US$ Bn), 2018 - 2031
      • 8.4.1.7. Egypt Shrimp Disease Diagnostics Market by Reagent, Value (US$ Bn), 2018 - 2031
      • 8.4.1.8. Egypt Shrimp Disease Diagnostics Market by Disease, Value (US$ Bn), 2018 - 2031
      • 8.4.1.9. Egypt Shrimp Disease Diagnostics Market by End User, Value (US$ Bn), 2018 - 2031
      • 8.4.1.10. Nigeria Shrimp Disease Diagnostics Market by Reagent, Value (US$ Bn), 2018 - 2031
      • 8.4.1.11. Nigeria Shrimp Disease Diagnostics Market by Disease, Value (US$ Bn), 2018 - 2031
      • 8.4.1.12. Nigeria Shrimp Disease Diagnostics Market by End User, Value (US$ Bn), 2018 - 2031
      • 8.4.1.13. Rest of Middle East & Africa Shrimp Disease Diagnostics Market by Reagent, Value (US$ Bn), 2018 - 2031
      • 8.4.1.14. Rest of Middle East & Africa Shrimp Disease Diagnostics Market by Disease, Value (US$ Bn), 2018 - 2031
      • 8.4.1.15. Rest of Middle East & Africa Shrimp Disease Diagnostics Market by End User, Value (US$ Bn), 2018 - 2031
    • 8.4.2. BPS Analysis/Market Attractiveness Analysis

9. Competitive Landscape

  • 9.1. Disease vs Reagent Heatmap
  • 9.2. Company Market Share Analysis, 2023
  • 9.3. Competitive Dashboard
  • 9.4. Company Profiles
    • 9.4.1. HiMedia Laboratories
      • 9.4.1.1. Company Overview
      • 9.4.1.2. Product Portfolio
      • 9.4.1.3. Financial Overview
      • 9.4.1.4. Business Strategies and Development
    • 9.4.2. Speedy Assay Sdn Bhd
      • 9.4.2.1. Company Overview
      • 9.4.2.2. Product Portfolio
      • 9.4.2.3. Financial Overview
      • 9.4.2.4. Business Strategies and Development
    • 9.4.3. REAGEN LLC
      • 9.4.3.1. Company Overview
      • 9.4.3.2. Product Portfolio
      • 9.4.3.3. Financial Overview
      • 9.4.3.4. Business Strategies and Development
    • 9.4.4. FUJIKURA KASEI CO., LTD.
      • 9.4.4.1. Company Overview
      • 9.4.4.2. Product Portfolio
      • 9.4.4.3. Financial Overview
      • 9.4.4.4. Business Strategies and Development
    • 9.4.5. GeneReach Biotechnology Corp.
      • 9.4.5.1. Company Overview
      • 9.4.5.2. Product Portfolio
      • 9.4.5.3. Financial Overview
      • 9.4.5.4. Business Strategies and Development
    • 9.4.6. Thermo Fisher Scientific
      • 9.4.6.1. Company Overview
      • 9.4.6.2. Product Portfolio
      • 9.4.6.3. Financial Overview
      • 9.4.6.4. Business Strategies and Development
    • 9.4.7. Lab - Ind Resource Sdn Bhd.
      • 9.4.7.1. Company Overview
      • 9.4.7.2. Product Portfolio
      • 9.4.7.3. Financial Overview
      • 9.4.7.4. Business Strategies and Development
    • 9.4.8. SUREBIO
      • 9.4.8.1. Company Overview
      • 9.4.8.2. Product Portfolio
      • 9.4.8.3. Financial Overview
      • 9.4.8.4. Business Strategies and Development
    • 9.4.9. Auro Biotechnologies Pvt. Ltd.
      • 9.4.9.1. Company Overview
      • 9.4.9.2. Product Portfolio
      • 9.4.9.3. Financial Overview
      • 9.4.9.4. Business Strategies and Development

10. Appendix

  • 10.1. Research Methodology
  • 10.2. Report Assumptions
  • 10.3. Acronyms and Abbreviations